Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2014 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (333)	6/12/2014 3:22:09 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 487

Placed bids during the bidding period, one block at 4.12 and one at 4.13. Both filled at open at 4 even. ?? Guess lucky is better than good. One of two buys is already sold. There's TONS of selling this news, quite the curiosity. Up 17% at the moment, to 4.50. Thanks again for the pointer, Marty. I've actually scalped it twice, tiny little plays, and then repurchased to hold into this news. So my yield is a little better than a buy-and-hold timed to your pointer. Unfortunately, did not play it for size.

To: scaram(o)uche who wrote (333)	6/13/2014 4:54:32 PM
From: Arthur Radley	Respond to of 487

Strange reaction today with PGNX vs NKTR----I attended the Adcom meeting this week and Salix group made a great presentation, as did the AZN group. NKTR responded well today--making me wonder if the AZN/NKTR drug getting approval this will take away the PGNX potential since it's not a pill delivery. Not complaining if that is the case as I've held NKTR for a long time and its good to final see something positive happening. In Philly tonight to see the Phillies and Cubs-----flooding rains as I write this! Bah, humbug.